Literature DB >> 3936665

Obstructive sleep apnea.

C E Sullivan, F G Issa.   

Abstract

This chapter provides an account of obstructive sleep apnea that is designed for clinicians. Current ideas about the mechanism of upper airway obstruction are reviewed, and the clinical features are discussed in a manner intended to facilitate the clinical assessment of such patients. Various forms of treatment are reviewed, with major emphasis given to the use of nasal positive airway pressure, a form of therapy developed by the authors.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3936665

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  14 in total

Review 1.  Pediatric origins of adult lung diseases. 3: the genesis of adult sleep apnoea in childhood.

Authors:  F McNamara; C E Sullivan
Journal:  Thorax       Date:  2000-11       Impact factor: 9.139

Review 2.  New developments in the use of positive airway pressure for obstructive sleep apnea.

Authors:  Lucas M Donovan; Schafer Boeder; Atul Malhotra; Sanjay R Patel
Journal:  J Thorac Dis       Date:  2015-08       Impact factor: 2.895

3.  Obstructive sleep apnoea due to a dermoid cyst of the floor of the mouth.

Authors:  J M Goldman; D J Barnes; D V Pohl
Journal:  Thorax       Date:  1990-01       Impact factor: 9.139

4.  CrossTalk opposing view: Loop gain is not a consequence of obstructive sleep apnoea.

Authors:  J E Orr; B A Edwards; A Malhotra
Journal:  J Physiol       Date:  2014-07-15       Impact factor: 5.182

Review 5.  Treatment of the obstructive sleep apnea syndrome.

Authors:  R V Wiggins; W W Schmidt-Nowara
Journal:  West J Med       Date:  1987-11

Review 6.  Control of the pharyngeal musculature during wakefulness and sleep: implications in normal controls and sleep apnea.

Authors:  Bradley A Edwards; David P White
Journal:  Head Neck       Date:  2011-09-07       Impact factor: 3.147

Review 7.  Diagnosis of obstructive sleep apnea.

Authors:  H W Bonekat; P E Krumpe
Journal:  Clin Rev Allergy       Date:  1990 Summer-Fall

8.  Adequacy of prescribing nasal continuous positive airway pressure therapy for the sleep apnoea/hypopnoea syndrome on the basis of night time respiratory recording variables.

Authors:  J M Montserrat; A Alarcón; P Lloberes; E Ballester; C Fornas; R Rodriguez-Roisin
Journal:  Thorax       Date:  1995-09       Impact factor: 9.139

9.  Plasma visfatin levels in severe obstructive sleep apnea-hypopnea syndrome.

Authors:  Georgia Trakada; Paschalis Steiropoulos; Evangelia Nena; Theodora Gkioka; Georgios Kouliatsis; Athanasia Pataka; Ioannis Sotiriou; Stavros Anevlavis; Nikolaos Papanas; Demosthenes Bouros
Journal:  Sleep Breath       Date:  2009-04-10       Impact factor: 2.816

10.  A novel nasopharyngeal stent for the treatment of obstructive sleep apnea: a case series of nasopharyngeal stenting versus continuous positive airway pressure.

Authors:  Maximilian Traxdorf; Michael Hartl; Florian Angerer; Christopher Bohr; Philipp Grundtner; Heinrich Iro
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-11-02       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.